Reversal of obesity by targeted ablation of adipose tissue

Nature Medicine

Volumn 10, Issue 6, 2004, Pages 625-632

  Kolonin, Mikhail G ^a   Saha, Pradip K ^b   Chan, Lawrence ^b   Pasqualini, Renata ^a   Arap, Wadih ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINYLLYSYLGLYCYLGLYCYLARGINYLALANYLLYSYLASPARTYLCYSTEINE; MEMBRANE PROTEIN; PEPTIDE; PROHIBITIN; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; AMINO ACID SEQUENCE; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CATHETER ABLATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LIPID METABOLISM; MOUSE; NONHUMAN; OBESITY; PHAGE DISPLAY; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN TARGETING; VASCULARIZATION; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; BLOOD VESSELS; DIET; ENERGY METABOLISM; HUMANS; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; PEPTIDE LIBRARY; PEPTIDES; REPRESSOR PROTEINS;

ANIMALIA;

EID: 2942703809     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1048     Document Type: Article

References (43)

1. Kopelman, P.G. Obesity as a medical problem. Nature 404, 635-643 (2000).
2. Leibel, R.L., Edens, N.K. & Fried, S.K. Physiologic basis for the control of body fat distribution in humans. Annu. Rev. Nutr. 9, 417-443 (1989).
3. Flegal, K.M., Carroll, M.D., Ogden, C.L. & Johnson, C.L. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288, 1723-1727 (2002).
4. Fontaine, K.R., Redden, D.T., Wang, C., Westfall, A.O. & Allison, D.B. Years of life lost due to obesity. JAMA 289, 187-193 (2003).
5. Masuzaki, H. et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 294, 2166-2170 (2001).
6. Spiegelman, B.M. & Flier, J.S. Obesity and the regulation of energy balance. Cell 104, 531-543 (2001).
7. Clapham, J.C., Arch, J.R. & Tadayyon, M. Anti-obesity drugs: a critical review of current therapies and future opportunities. Pharmacol. Ther. 89, 81-121 (2001).
8. Woods, S.C. & Seeley, R.J. Adiposity signals and the control of energy homeostasis. Nutrition 16, 894-902 (2000).
9. Leibowitz, S.F. Brain peptides and obesity: pharmacologic treatment. Obes. Res. 3 (suppl. 4), 573-589 (1995).
10. O'Reilly, M.S. et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328 (1994).
11. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27-31 (1995).
12. Folkman, J. Addressing tumor blood vessels. Nat. Biotechnol. 15, 510 (1997).
13. Carmeliet, P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6, 389-395 (2000).
14. Eliceiri, B.P. & Cheresh, D.A. Adhesion events in angiogenesis. Curr. Opin. Cell Biol. 13, 563-568 (2001).
15. Burrows, F.J. & Thorpe, P.E. Vascular targeting - a new approach to the therapy of solid tumors. Pharmacol. Ther. 64, 155-174 (1994).
16. Zetter, B.R. Angiogenesis and tumor metastasis. Annu. Rev. Med. 49, 407-424 (1998).
17. Wasserman, F. The development of adipose tissue. in Handbook of Physiology Vol. 5 (eds. Renold, A. & Cahill, G.) 87-100 (American Physiological Society, Washington, D.C., 1965).
18. Cinti, S. Anatomy of the adipose organ. Eat. Weight Disord. 5, 132-142 (2000).
19. Sumi, T., Ishiko, O., Yoshida, H., Hyun, Y. & Ogita, S. Involvement of angiogenesis in weight-loss in tumor-bearing and diet-restricted animals. Int. J. Mol. Med. 8, 533-536 (2001).
20. Crandall, D.L., Hausman, G.J. & Kral, J.G. A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation 4, 211-232 (1997).
21. Rupnick, M.A. et al. Adipose tissue mass can be regulated through the vasculature. Proc. Natl. Acad. Sci. USA 99, 10730-10735 (2002).
22. Greene, A.K. et al. Endothelial-directed hepatic regeneration after partial hepatectomy. Ann. Surg. 237, 530-535 (2003).
23. Kolonin, M.G., Pasqualini, R. & Arap, W. Molecular addresses in blood vessels as targets for therapy. Curr. Opin. Chem. Biol. 5, 308-313 (2001).
24. Pasqualini, R., Arap, W., Rajotte, D. & Ruoslahti, E. In vivo selection of phage-display libraries. in Phage Display: A Laboratory Manual (eds. Barbas, C., Burton, D., Silverman, G. & Scott, J.) 22.1-22.24 (Cold Spring Harbor Laboratory Press, New York, NY, 2000).
25. Kolonin, M.G., Pasqualini, R. & Arap, W. Teratogenicity induced by targeting a placental immunoglobulin transporter. Proc. Natl. Acad. Sci. USA 99, 13055-13060 (2002).
26. Pasqualini, R. & Ruoslahti, E. Organ targeting in vivo using phage display peptide libraries. Nature 380, 364-366 (1996).
27. Arap, W. et al. Steps toward mapping the human vasculature by phage display. Nat. Med. 8, 121-127 (2002).
28. Zhang, Y. et al. Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432 (1994).
29. Licinio, J. et al. Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc. Natl. Acad. Sci. USA 101, 4531-4536 (2004).
30. Ellerby, H.M. et al. Anti-cancer activity of targeted pro-apoptotic peptides. Nat. Med. 5, 1032-1038 (1999).
31. McClung, J.K., Jupe, E.R., Liu, X.T. & Dell'Orco, R.T. Prohibitin: potential role in senescence, development, and tumor suppression. Exp. Gerontol. 30, 99-124 (1995).
32. Lamers, M.C. & Bacher, S. Prohibitin and prohibitone, ubiquitous and abundant proteins that are reluctant to reveal their real identity. Int. Arch. Allergy Immunol. 113, 146-149 (1997).
33. Coates, P.J. et al. Mammalian prohibitin proteins respond to mitochondrial stress and decrease during cellular senescence. Exp. Cell. Res. 265, 262-273 (2001).
34. Nijtmans, L.G. et al. Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins. EMBO J. 19, 2444-2451 (2000).
35. Fusaro, G., Wang, S. & Chellappan, S. Differential regulation of Rb family proteins and prohibitin during camptothecin-induced apoptosis. Oncogene 21, 4539-4548 (2002).
36. Terashima, M. et al. The IgM antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin-related protein. EMBO J. 13, 3782-3792 (1994).
37. Shimomura, I. et al. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev. 12, 3182-3194 (1998).
38. Moitra, J. et al. Life without white fat: a transgenic mouse. Genes Dev. 12, 3168-3181 (1998).
39. Zabolotny, J.M. et al. PTP1B regulates leptin signal transduction in vivo. Dev. Cell 2, 489-495 (2002).
40. Bluher, M., Kahn, B.B. & Kahn, C.R. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299, 572-574 (2003).
41. McConkey, D.J., Goodrich, D., Bucana, C. & Klostergaard, J. The human retinoblastoma gene product suppresses ceramide-induced apoptosis in human bladder tumor cells. Oncogene 13, 1693-1700 (1996).
42. Zhu, Y. et al. Genomic interval engineering of mice identifies a novel modulator of triglyceride production. Proc. Natl. Acad. Sci. USA 97, 1137-1142 (2000).
43. Rajotte, D. & Ruoslahti, E. Membrane dipeptidase is the receptor for a lung-targeting peptide identified by in vivo phage display. J. Biol. Chem. 274, 11593-11598 (1999).